|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/517 | |
| A61K 45/06 | |||
| A61K 31/337 | |||
| A61K 31/7068 | |||
| A61K 39/395 | |||
| A61P 35/04 | |||
| A61P 35/00 |
| (11) | Number of the document | 3400943 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18162971.8 |
| Date of filing the European patent application | 2013-03-25 | |
| (97) | Date of publication of the European application | 2018-11-14 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-02 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261615082 P | 2012-03-23 | US |
| (72) |
LEE, Patrice A., US
WINSKI, Shannon L., US
KOCH, Kevin, US
|
| (73) |
Array Biopharma, Inc.,
3200 Walnut Street, Boulder, CO 80301,
US
|
| (54) | COMPOUNDS FOR USE IN THE TREATMENT OF BRAIN METASTASES IN A PATIENT WITH ERBB2+ BREAST CANCER |
| COMPOUNDS FOR USE IN THE TREATMENT OF BRAIN METASTASES IN A PATIENT WITH ERBB2+ BREAST CANCER |